Event: New Date for BioCrossroads Indiana Life Sciences Summit

2021-06-15T12:25:44-04:00June 15, 2021|

The Indiana Life Sciences Summit drives conversations and provides content on important and timely topics with speakers from Indiana’s life sciences community. Coming out of a global pandemic, this year's virtual conference will focus on opportunities for the life sciences sector based on what we've learned, what needs to change and how we innovate moving forward. Local and national thought leaders will provide their insights and perspectives; we will present our annual Watanabe Life Science Champion of the Year award; and we hope to have some surprises, too. Stay tuned for more details and registration information coming in July. For sponsorship information, contact JoBeth Zimmerman. WHEN: Wednesday, Oct. 13, 2021 From 10:00 AM – 1:00 PM WHERE: Online VIRTUAL Event 

IIB Perspectives: Renewed Focus on University Tech Transfer Drives Life Sciences Innovation

2021-04-19T12:01:35-04:00April 19, 2021|

By: Patty Martin, President and CEO, BioCrossroads Indiana universities and companies have played a vital role in the commercialization of insulin, the treatment of prostate cancer, and a reduction in cancer cases caused by the human papillomavirus, among many other therapeutics. Importantly, Hoosier state universities—Indiana University, Purdue University and Notre Dame—have made significant contributions to medical innovation over the past few decades. All of this, including the boost to Indiana’s economy from this wave of innovation, has been supported and enabled by a little-known law with an enormous impact, the University and Small Business Patent Procedures Act of 1980. The Economist characterized the law, more commonly known as the Bayh-Dole Act, an eponymous shorthand referring to the two senators, Birch Bayh and Bob Dole, who co-authored the legislation, as “possibly the most inspired piece of legislation to be enacted in America [...]

Indiana’s life sciences companies accessed more than $9 billion to grow innovation in 2020 BioCrossroads report details funding sources, deals, investors

2021-05-05T06:36:06-04:00April 12, 2021|

INDIANAPOLIS (April 12, 2021) --   In 2020, Indiana’s life sciences companies accessed over $9 billion in capital to grow and support innovation. The funding comes from a variety of sources including Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards, venture capital, initial public offerings and related public offerings, and mergers and acquisitions. BioCrossroads today issued their annual report, Indiana Life Sciences Capital 2020, which provides details on the funding events throughout the year. The $9 billion includes: $12.6 million SBIR awarded to 21 companies. $262 million in venture capital invested in 44 companies. $141.8 million accessed through public markets by three companies. $8.6 billion+ spent to acquire innovation, representing nine transactions. The market capitalization for Indiana’s public life sciences companies as of Dec. 31, 2020 was $297.6 billion and includes Eli Lilly and Company, Anthem, Zimmer [...]

Indiana’s life sciences industry breaks yearly records in two key categories – exports and venture capital

2021-04-21T11:21:42-04:00March 25, 2021|

INDIANAPOLIS, (March 25, 2021) --   While COVID-19 continues to make the headlines, Indiana’s life sciences industry not only combatted the pandemic with testing, treatments, clinical trials, and vaccine manufacturing but remained committed to innovating and investing throughout 2020. New data provided to BioCrossroads by the Indiana Business Research Center (IBRC) at the Indiana University Kelley School of Business shows a thriving and growing sector. One of the most notable milestones: Indiana is the second highest exporter of life sciences products in the U.S. and has been for more than a decade.  In 2020, more than $11.4 billion of products were exported from the state, representing more than $192,000 of output per worker, the highest amount ever recorded. In addition, Indiana life sciences start-ups garnered a record level of venture capital investment with more than $262 million committed to 44 companies, [...]

BioCrossroads report underscores importance of strong tech transfer programs at Indiana’s research universities

2021-04-05T16:47:42-04:00November 19, 2020|

INDIANAPOLIS, (Nov. 19, 2020) -- BioCrossroads today released a new report, Tech Transfer in Indiana: An Overview for the Life Sciences Industry, a comprehensive resource highlighting the technology transfer processes and approaches used by Indiana University, Purdue University and the University of Notre Dame to facilitate commercialization of research-driven discoveries and innovations. The report also discusses the role of incubators and graduation facilities at research universities, which are increasing in number and importance. “With our three research institutions and thousands of research faculty, Indiana has critical assets necessary to drive innovation. University labs and facilities are especially important for life sciences R&D that require unique space and equipment required to perform complex research,” said Patricia Martin, president and CEO, BioCrossroads. In addition to developing breakthroughs in medical treatments and therapies, Indiana’s three R11 research institutions also generate a substantial amount of [...]

Richard M. Fairbanks Foundation grants BioCrossroads funding to advance collaborative and educational life sciences initiatives

2021-04-05T16:47:42-04:00October 29, 2020|

INDIANAPOLIS (Oct. 29, 2020) --  BioCrossroads announced today that the Richard M. Fairbanks Foundation has made a grant of $1.35 million to the organization to continue to advance the strength and opportunities of several collaborative and educational initiatives within Indiana’s life sciences sector. The Fairbanks Foundation is an Indianapolis-based, independent, private foundation focused on the education, health and the vitality of the Indianapolis community. “The life sciences sector is a key driver of Indiana’s economy, accounting for 20% of the state’s GDP. BioCrossroads plays a critical role helping to create an environment in which this sector can flourish,” said Claire Fiddian-Green, president and CEO of the Richard M. Fairbanks Foundation. “We are pleased to provide continued support for the organization and its key initiatives.” The two-year grant enables BioCrossroads to continue to advance Indiana’s vitality in the life sciences via [...]

Indiana’s premier drug development and manufacturing sector adds another company to its ecosystem

2021-04-05T16:47:43-04:00October 15, 2020|

INCOG BioPharma Services, Inc. announced plans to build new facility in Fishers, Ind., add 150 new jobs INDIANAPOLIS (Oct. 15, 2020) - Indiana is one of the premier contract drug development and manufacturing centers in the United States. These pharmaceutical contract service providers support the growing outsourcing needs of both large pharmaceutical and smaller biotechnology companies. Nearly 40 contract research and manufacturing organizations employ more than 7,000 workers throughout the state. Companies like Covance Central Labs (Indianapolis), Catalent Biologics (Bloomington) and B2S Life Sciences (Franklin) provide pre-clinical testing, toxicology, product manufacturing and other support to pharmaceutical companies worldwide. Pharmaceutical and biotechnology companies would not be able to discover, develop and distribute their products without these important partners. This week, INCOG BioPharma announced that they are forming a new biopharmaceutical manufacturing company in Fishers, Ind. Formed by an experienced management team, [...]

Developer of Echocardiography Dr. Harvey Feigenbaum honored as BioCrossroads 2020 Life Sciences Champion of the Year

2021-04-05T16:47:43-04:00October 7, 2020|

INDIANAPOLIS (Oct. 7, 2020) — BioCrossroads’ Board of Directors named esteemed “Father of Echocardiography” (Echo) Dr. Harvey Feigenbaum, as the recipient of the 2020 August M. Watanabe Life Sciences Champion of the Year Award. The prestigious honor, named in tribute to BioCrossroads’ late Chairman August Watanabe, was given to Dr. Feigenbaum at today’s Indiana Life Sciences Summit for his unprecedented impact on cardiac health in Indiana and around the world. Dr. Feigenbaum is recognized for pioneering the Echo, the most widely used cardiac imaging technique in the world. Dr. Feigenbaum has made numerous contributions to the medical profession that include developing the world’s first practical, long lasting use of echocardiography, the use of ultrasound to examine the heart, in 1965. He fought and overcame many years of skepticism by training many early world-wide pioneers in echocardiography and the first cardiac sonographer. [...]

Go to Top